We're excited to welcome Vini Gautam, Indian Institute of Science (IISc), to our #ECAB for #BJNANO 💎🔓.
🔗 https://tinyurl.com/5ds284dm
Vini focuses on neuroengineering, biomaterials, bioelectronics, blending materials science and physics to develop novel neural stimulation & interfacing technologies.
🔗 https://tinyurl.com/5ds284dm
Vini focuses on neuroengineering, biomaterials, bioelectronics, blending materials science and physics to develop novel neural stimulation & interfacing technologies.
February 18, 2026 at 9:01 AM
We're excited to welcome Vini Gautam, Indian Institute of Science (IISc), to our #ECAB for #BJNANO 💎🔓.
🔗 https://tinyurl.com/5ds284dm
Vini focuses on neuroengineering, biomaterials, bioelectronics, blending materials science and physics to develop novel neural stimulation & interfacing technologies.
🔗 https://tinyurl.com/5ds284dm
Vini focuses on neuroengineering, biomaterials, bioelectronics, blending materials science and physics to develop novel neural stimulation & interfacing technologies.
We are excited to welcome Vini Gautam, Indian Institute of Science (IISc), as a new member of our #earlycareeradvisoryboard #ecab for the Beilstein Journal of Nanotechnology.
🔗 https://www.beilstein-journals.org/bjnano/boardMembers/48880671?M=y
Vini focuses […]
[Original post on hessen.social]
🔗 https://www.beilstein-journals.org/bjnano/boardMembers/48880671?M=y
Vini focuses […]
[Original post on hessen.social]
February 18, 2026 at 9:00 AM
We are excited to welcome Vini Gautam, Indian Institute of Science (IISc), as a new member of our #earlycareeradvisoryboard #ecab for the Beilstein Journal of Nanotechnology.
🔗 https://www.beilstein-journals.org/bjnano/boardMembers/48880671?M=y
Vini focuses […]
[Original post on hessen.social]
🔗 https://www.beilstein-journals.org/bjnano/boardMembers/48880671?M=y
Vini focuses […]
[Original post on hessen.social]
We warmly welcome Omur E. Dagdeviren @etsmtl.bsky.social, as a member of our #ECAB for #BJNANO 💎🔓.
🔗 https://tinyurl.com/4pwy2yhm
Omur is co-editing the thematic issue "At the cutting edge of atomic force microscopy" https://tinyurl.com/4fr7b4s7 Contact Omur if you are interested in submitting.
🔗 https://tinyurl.com/4pwy2yhm
Omur is co-editing the thematic issue "At the cutting edge of atomic force microscopy" https://tinyurl.com/4fr7b4s7 Contact Omur if you are interested in submitting.
February 13, 2026 at 9:01 AM
We warmly welcome Omur E. Dagdeviren @etsmtl.bsky.social, as a member of our #ECAB for #BJNANO 💎🔓.
🔗 https://tinyurl.com/4pwy2yhm
Omur is co-editing the thematic issue "At the cutting edge of atomic force microscopy" https://tinyurl.com/4fr7b4s7 Contact Omur if you are interested in submitting.
🔗 https://tinyurl.com/4pwy2yhm
Omur is co-editing the thematic issue "At the cutting edge of atomic force microscopy" https://tinyurl.com/4fr7b4s7 Contact Omur if you are interested in submitting.
We warmly welcome Omur E. Dagdeviren, École de technologie supérieure (ÈTS), as a new member of our #earlycareeradvisoryboard #ecab for the Beilstein Journal of Nanotechnology.
🔗 https://www.beilstein-journals.org/bjnano/boardMembers/48880541?M=y
Omur is […]
[Original post on hessen.social]
🔗 https://www.beilstein-journals.org/bjnano/boardMembers/48880541?M=y
Omur is […]
[Original post on hessen.social]
February 13, 2026 at 9:00 AM
We warmly welcome Omur E. Dagdeviren, École de technologie supérieure (ÈTS), as a new member of our #earlycareeradvisoryboard #ecab for the Beilstein Journal of Nanotechnology.
🔗 https://www.beilstein-journals.org/bjnano/boardMembers/48880541?M=y
Omur is […]
[Original post on hessen.social]
🔗 https://www.beilstein-journals.org/bjnano/boardMembers/48880541?M=y
Omur is […]
[Original post on hessen.social]
📢 We are excited to announce the onboarding of three new Early Career Editorial Board Members at the #BJNANO 💎🔓: Omur E. Dagdeviren @etsmtl.bsky.social, Vini Gautam, Indian Institute of Science (IISc) and Samuel S. Veroneau @upenn.edu.
Welcome aboard!
🔗 https://tinyurl.com/mr2sxvej
#ECAB
Welcome aboard!
🔗 https://tinyurl.com/mr2sxvej
#ECAB
February 6, 2026 at 9:02 AM
📢 We are excited to announce the onboarding of three new Early Career Editorial Board Members at the #BJNANO 💎🔓: Omur E. Dagdeviren @etsmtl.bsky.social, Vini Gautam, Indian Institute of Science (IISc) and Samuel S. Veroneau @upenn.edu.
Welcome aboard!
🔗 https://tinyurl.com/mr2sxvej
#ECAB
Welcome aboard!
🔗 https://tinyurl.com/mr2sxvej
#ECAB
Le CAB est passé en eCAB 👀
January 29, 2026 at 7:05 PM
Le CAB est passé en eCAB 👀
📣 We’re looking for new members for our Board and Early Career Advisory Board (PhD / postdoc / PI) who care about EDIA and want to help guide the direction of WISC.
🗓 Deadline: Jan 31
👥 Open to all
👉 Apply here: www.womeninsuprachem.com/board-ecab-r...
#WomenInSTEM #SupramolecularChemistry
🗓 Deadline: Jan 31
👥 Open to all
👉 Apply here: www.womeninsuprachem.com/board-ecab-r...
#WomenInSTEM #SupramolecularChemistry
January 11, 2026 at 7:47 PM
📣 We’re looking for new members for our Board and Early Career Advisory Board (PhD / postdoc / PI) who care about EDIA and want to help guide the direction of WISC.
🗓 Deadline: Jan 31
👥 Open to all
👉 Apply here: www.womeninsuprachem.com/board-ecab-r...
#WomenInSTEM #SupramolecularChemistry
🗓 Deadline: Jan 31
👥 Open to all
👉 Apply here: www.womeninsuprachem.com/board-ecab-r...
#WomenInSTEM #SupramolecularChemistry
Call for Papers! Thematic issue “Shaping the future of nanotechnology” ed. by our Early Career Advisory Board (#ECAB) members Thies H. Büscher @tbuescher.bsky.social , Hao Lu and Yui Sasaki in the #BJNANO 💎🔓 is open for your submission:
➡️ https://tinyurl.com/34vae3mf
#MaterialsDesign #biocatalysis
➡️ https://tinyurl.com/34vae3mf
#MaterialsDesign #biocatalysis
January 8, 2026 at 9:01 AM
Call for Papers! Thematic issue “Shaping the future of nanotechnology” ed. by our Early Career Advisory Board (#ECAB) members Thies H. Büscher @tbuescher.bsky.social , Hao Lu and Yui Sasaki in the #BJNANO 💎🔓 is open for your submission:
➡️ https://tinyurl.com/34vae3mf
#MaterialsDesign #biocatalysis
➡️ https://tinyurl.com/34vae3mf
#MaterialsDesign #biocatalysis
To be clear, I would not have more Beavers or Cowser for Cabrera. I might have considered Mayo or EBJ, but not after acquiring Baz, who is similar and makes ECab less of a value add.
January 7, 2026 at 5:23 PM
To be clear, I would not have more Beavers or Cowser for Cabrera. I might have considered Mayo or EBJ, but not after acquiring Baz, who is similar and makes ECab less of a value add.
Man I am gonna end up hating this winter for the Yankees aren't I? Barely whispers about Bellinger, total silence regarding Tucker, immediately losing out on ECab right after smoke about it...
Cubs are acquiring Edward Cabrera. I'll have opinions later, but for now, that should make you feel like the Cubs are more likely to end up with Bregman or Bichette now.
January 7, 2026 at 5:10 PM
Man I am gonna end up hating this winter for the Yankees aren't I? Barely whispers about Bellinger, total silence regarding Tucker, immediately losing out on ECab right after smoke about it...
I think Baz and Cabrera are pretty interchangeable, though I’d bet on Baz for innings (just don’t think ECab can physically stand up to 150+ innings and his command prevents him from going deep). If the trade package is way lighter I’ll be annoyed, but otherwise happy with Baz in this role.
January 4, 2026 at 8:05 PM
I think Baz and Cabrera are pretty interchangeable, though I’d bet on Baz for innings (just don’t think ECab can physically stand up to 150+ innings and his command prevents him from going deep). If the trade package is way lighter I’ll be annoyed, but otherwise happy with Baz in this role.
Yeah, this makes complete sense. They wanted to pull off a trade for a young, controllable starter with upside, and they got Baz, who is IMO a better target. Baz + ECab would be too much variance and durability risk. Better to try hard for a guy at the top of the market now.
December 26, 2025 at 11:18 PM
Yeah, this makes complete sense. They wanted to pull off a trade for a young, controllable starter with upside, and they got Baz, who is IMO a better target. Baz + ECab would be too much variance and durability risk. Better to try hard for a guy at the top of the market now.
The Emergency Change Advisory Board (ECAB) manages urgent changes by assessing risks, streamlining processes, and ensuring clear communication to minimise disruption. It’s essential for business continuity and quick decision-making. #AdvisoryBoards
The Emergency Change Advisory Board (ECAB) manages urgent changes by assessing risks, streamlining processes, and ensuring clear communication to minimise disruption. It’s essential for business continuity and quick decision-making. #AdvisoryBoards
The Emergency Change Advisory Board (ECAB) manages urgent changes by assessing risks, streamlining processes, and ensuring clear communication to minimise disruption. It’s essential for business continuity and quick decision-making. #AdvisoryBoards
boardroomadvisors.co
December 22, 2025 at 8:10 AM
The Emergency Change Advisory Board (ECAB) manages urgent changes by assessing risks, streamlining processes, and ensuring clear communication to minimise disruption. It’s essential for business continuity and quick decision-making. #AdvisoryBoards
ECAB member Máté Bezdek t.co/FjAni1RhVZ favorite @helvchimacta.bsky.social article is the one of Alex Adronov because the authors elegantly craft a polymer with affinity for metallic tubes, yielding cleaner dispersions and films with enhanced conductivity doi.org/10.1002/hlca...
December 11, 2025 at 4:52 PM
ECAB member Máté Bezdek t.co/FjAni1RhVZ favorite @helvchimacta.bsky.social article is the one of Alex Adronov because the authors elegantly craft a polymer with affinity for metallic tubes, yielding cleaner dispersions and films with enhanced conductivity doi.org/10.1002/hlca...
Look, there’s a lot to like about ECab. I’ve been interested in him for years, he’s still 3 years from FA & he’s coming off his best season.
But he still couldn’t crack 140 IP. He’s just not a durable or dependable starter. There’s definitely talent but didn’t you just give up on Grayson Rodriguez?
But he still couldn’t crack 140 IP. He’s just not a durable or dependable starter. There’s definitely talent but didn’t you just give up on Grayson Rodriguez?
December 10, 2025 at 1:50 AM
Look, there’s a lot to like about ECab. I’ve been interested in him for years, he’s still 3 years from FA & he’s coming off his best season.
But he still couldn’t crack 140 IP. He’s just not a durable or dependable starter. There’s definitely talent but didn’t you just give up on Grayson Rodriguez?
But he still couldn’t crack 140 IP. He’s just not a durable or dependable starter. There’s definitely talent but didn’t you just give up on Grayson Rodriguez?
Well this certainly makes me want to feel better.
pca.st/episode/ecab...
pca.st/episode/ecab...
Tech Billionaires & the Rural Poor: Two Sides of Trump’s MAGA Populism
pca.st
December 5, 2025 at 2:28 PM
Well this certainly makes me want to feel better.
pca.st/episode/ecab...
pca.st/episode/ecab...
Es muss ECAB heißen, dann ist es keine Beleidigung mehr.
November 30, 2025 at 2:36 PM
Es muss ECAB heißen, dann ist es keine Beleidigung mehr.
Novo Nordisk shares slump after drug failure in Alzheimer’s trial—Novo has endured a tumultuous year, which has led to a boardroom clearout, while its share price has fallen about 60 per cent in the past 12 months… www.ft.com/content/ecab... Aanu Adeoye @financialtimes.com
Novo Nordisk shares slump after drug failure in Alzheimer’s trial
Outcome is blow to one of Europe’s largest listed companies
www.ft.com
November 27, 2025 at 2:02 AM
Novo Nordisk shares slump after drug failure in Alzheimer’s trial—Novo has endured a tumultuous year, which has led to a boardroom clearout, while its share price has fallen about 60 per cent in the past 12 months… www.ft.com/content/ecab... Aanu Adeoye @financialtimes.com
Novo Nordisk shares slump after drug failure in Alzheimer’s trial www.ft.com/content/ecab... via @ft
Novo Nordisk shares slump after drug failure in Alzheimer’s trial
Outcome is blow to one of Europe’s largest listed companies
www.ft.com
November 24, 2025 at 4:43 PM
Novo Nordisk shares slump after drug failure in Alzheimer’s trial www.ft.com/content/ecab... via @ft
„Novo has endured a tumultuous year, which has led to a boardroom clearout, while its share price has fallen about 60 per cent in the past 12 months.“
www.ft.com/content/ecab...
www.ft.com/content/ecab...
Novo Nordisk shares slump after drug failure in Alzheimer’s trial
Outcome is blow to one of Europe’s largest listed companies
www.ft.com
November 24, 2025 at 1:33 PM
„Novo has endured a tumultuous year, which has led to a boardroom clearout, while its share price has fallen about 60 per cent in the past 12 months.“
www.ft.com/content/ecab...
www.ft.com/content/ecab...
This paper, chosen as part of JACS Au's ECAB Selects program, presents an ab initio approach to study molecules containing heavy atoms strongly interacting with quantum fields in optical devices. buff.ly/uMfVMtp
November 22, 2025 at 7:08 PM
This paper, chosen as part of JACS Au's ECAB Selects program, presents an ab initio approach to study molecules containing heavy atoms strongly interacting with quantum fields in optical devices. buff.ly/uMfVMtp
The findings demonstrated in this paper, chosen as part of JACS Au's ECAB Selects program, demonstrate the utility of luminescence in Cas13 diagnostics and reveal the potential applications of this platform to activity-based enzymatic sensing. buff.ly/DErEjAt
November 19, 2025 at 5:19 PM
The findings demonstrated in this paper, chosen as part of JACS Au's ECAB Selects program, demonstrate the utility of luminescence in Cas13 diagnostics and reveal the potential applications of this platform to activity-based enzymatic sensing. buff.ly/DErEjAt
ECAB member Emmanuelle Allouche www.siegfried.ch favorite @helvchimacta.bsky.social article is the one of @novartis.bsky.social because it describes the development of a safe and scalable difluoromethylation of 3-hydroxypyridines using continuous-flow technology doi.org/10.1002/hlca...
November 17, 2025 at 10:24 AM
ECAB member Emmanuelle Allouche www.siegfried.ch favorite @helvchimacta.bsky.social article is the one of @novartis.bsky.social because it describes the development of a safe and scalable difluoromethylation of 3-hydroxypyridines using continuous-flow technology doi.org/10.1002/hlca...